Lipid partitioning at the nuclear envelope controls membrane biogenesis

Cells must balance lipid precursor allocation between membrane synthesis and storage to maintain growth and adapt to changing environments. Disruptions in this balance are linked to diseases like cancer and diabetes. Prior research has shown that phospholipid synthesis dominates under nutrient-rich conditions, while triacylglycerol (TAG) storage occurs during starvation. However, the signals and mechanisms that control this reprogramming remain unclear. This gap motivated researchers to explore how lipid metabolism is regulated at the nuclear envelope. Understanding these processes could improve insights into metabolic diseases. Current models lack detailed mechanisms linking lipid precursor partitioning to cellular growth signals. No prior work had resolved how the nuclear membrane contributes to this process. This study addresses these uncertainties by focusing on the conserved enzyme Pah1 and its role in lipid metabolism.

The study aimed to uncover how cells regulate lipid precursor partitioning between membrane biogenesis and storage. Researchers focused on the nuclear envelope, a key site for lipid metabolism. They investigated the role of Pah1, a phosphatidate phosphatase, in this process. The goal was to determine how Pah1 activity is controlled by cellular metabolic status. The team also sought to understand how lipid precursor allocation affects nuclear structure and proliferation of endoplasmic reticulum membranes. They hypothesized that Pah1 acts as a switch to control lipid fate. This work addresses a critical gap in understanding how lipid metabolism is coordinated with growth signals. The findings may clarify how disruptions in this process contribute to disease.

The researchers used yeast as a model system to study lipid metabolism at the nuclear envelope. They focused on the enzyme Pah1 and its interaction with the nuclear membrane. Fluorescence microscopy was employed to track Pah1 localization and lipid droplet formation. They manipulated cellular pH to assess the effects of cytosol acidification on Pah1 activity. Genetic tools were used to disrupt TAG storage and observe changes in lipid precursor allocation. Electron microscopy was applied to visualize nuclear deformation and ER membrane proliferation. Quantitative lipidomics measured changes in phospholipid and TAG levels. The study combined biochemical assays with live-cell imaging to link Pah1 activity to metabolic signals.

The study found that Pah1 localizes to a nuclear membrane subdomain in contact with lipid droplets. This localization is essential for TAG synthesis during starvation. Cytosol acidification activates the Nem1-Spo7 complex, which regulates Pah1 activity. When TAG storage is impaired, Pah1 remains at the nuclear membrane but redirects precursors to phospholipid synthesis. This shift leads to nuclear deformation and ER membrane proliferation. The absence of TAG storage capacity disrupts normal lipid partitioning. Pah1 activity is tightly linked to cellular metabolic status. These findings suggest that Pah1 acts as a metabolic switch at the nuclear envelope. The results provide direct evidence for how lipid precursor allocation is controlled in response to growth signals.

The authors propose that Pah1 activity at the nuclear envelope controls the balance between membrane biogenesis and lipid storage. This mechanism is activated in response to growth signals and cytosol acidification. The findings suggest that Pah1 serves as a metabolic switch. The study shows that lipid precursor allocation is regulated by the nuclear membrane's interaction with lipid droplets. When TAG storage is impaired, phospholipid synthesis increases, leading to nuclear deformation. This process is mediated by the Nem1-Spo7 complex. The results support the idea that lipid metabolism is tightly coordinated with cellular growth status. These conclusions are based on the observed effects of Pah1 localization and activity in yeast cells.